| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |